Stone JH, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539–551. https://doi.org/10.1056/NEJMra1104650

Article  CAS  PubMed  Google Scholar 

Sato Y, Notohara K, Kojima M (2010) IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 60(4):247–258. https://doi.org/10.1111/j.1440-1827.2010.02524.x

Article  CAS  PubMed  Google Scholar 

Kamisawa T, Funata N, Hayashi Y (2003) A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 38(10):982–984. https://doi.org/10.1007/s00535-003-1175-y

Article  CAS  PubMed  Google Scholar 

Stone JH, Khosroshahi A, Hilgenberg A et al (2009) IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 60(10):3139–3145. https://doi.org/10.1002/art.24798

Article  PubMed  Google Scholar 

Saeki T, Saito A, Hiura T et al (2006) Lymphoplasmacytic infiltration of multiple organs with immunoreactivity for IgG4: IgG4-related systemic disease. Intern Med 45(3):163–167. https://doi.org/10.2169/internalmedicine.45.1431

Article  PubMed  Google Scholar 

Kamisawa T, Takuma K, Egawa N et al (2010) Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 7(7):401–409. https://doi.org/10.1038/nrgastro.2010.81

Article  CAS  PubMed  Google Scholar 

Rotondi M, Carbone A, Coperchini F et al (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180(5):R175–R183. https://doi.org/10.1530/EJE-18-1024

Article  CAS  PubMed  Google Scholar 

Zhang J, Zhao L, Gao Y et al (2014) A classification of Hashimoto’s thyroiditis based on immunohistochemistry for IgG4 and IgG. Thyroid 24(2):364–370. https://doi.org/10.1089/thy.2013.0211

Article  CAS  PubMed  Google Scholar 

Li Y, Bai Y, Liu Z et al (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int 59(9):636–641. https://doi.org/10.1111/j.1440-1827.2009.02419.x

Article  CAS  PubMed  Google Scholar 

Li Y, Nishihara E, Hirokawa M et al (2010) Distinct clinical, serological, and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 95(3):1309–1317. https://doi.org/10.1210/jc.2009-1794

Article  CAS  PubMed  Google Scholar 

Li Y, Zhou G, Ozaki T et al (2012) Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol 25(8):1086–1097. https://doi.org/10.1038/modpathol.2012.68

Article  PubMed  Google Scholar 

Stan MN, Sonawane V, Sebo TJ et al (2017) Riedel’s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf) 86(3):425–430. https://doi.org/10.1111/cen.13238

Article  CAS  PubMed  Google Scholar 

Dahlgren M, Khosroshahi A, Nielsen GP et al (2010) Riedel’s thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 62(9):1312–1318. https://doi.org/10.1002/acr.20215

Article  PubMed  Google Scholar 

Takeshima K, Inaba H, Furukawa Y et al (2014) Elevated serum immunoglobulin G4 levels in patients with Graves’ disease and their clinical implications. Thyroid 24(4):736–743. https://doi.org/10.1089/thy.2013.0448

Article  CAS  PubMed  Google Scholar 

Martin CS, Sirbu AE, Betivoiu MA et al (2017) Serum immunoglobulin G4 levels and Graves’ disease phenotype. Endocrine 55(2):478–484. https://doi.org/10.1007/s12020-016-1157-5

Article  CAS  PubMed  Google Scholar 

Torimoto K, Okada Y, Kurozumi A et al (2017) Clinical features of patients with Basedow’s disease and high serum IgG4 levels. Intern Med 56(9):1009–1013. https://doi.org/10.2169/internalmedicine.56.7824

Article  PubMed  PubMed Central  Google Scholar 

Deng Y, Wang J, Zou G et al (2022) The characteristics and clinical significance of elevated serum IgG4/IgG levels in patients with Graves’ disease. Endocrine 75(3):829–836. https://doi.org/10.1007/s12020-021-02935-3

Article  CAS  PubMed  Google Scholar 

Ye H, Xiao W, Chen R et al (2020) Elevated immunoglobulin G4 levels in patients with thyroid eye disease and their clinical implications. Invest Ophthalmol Vis Sci 61(5):57. https://doi.org/10.1167/iovs.61.5.57

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bozkirli E, Bakiner OS, Ersozlu Bozkirli ED et al (2015) Serum immunoglobulin G4 levels are elevated in patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf) 83(6):962–967. https://doi.org/10.1111/cen.12671

Article  CAS  PubMed  Google Scholar 

Luo B, Yuan X, Wang W et al (2022) Ocular Manifestations and Clinical Implications of Serum Immunoglobulin G4 Levels in Graves’ Ophthalmopathy Patients. Ocul Immunol Inflamm 30(3):580–587. https://doi.org/10.1080/09273948.2020.1826537

Article  CAS  PubMed  Google Scholar 

Yu SH, Kang JG, Kim CS et al (2017) Clinical Implications of Immunoglobulin G4 to Graves’ Ophthalmopathy. Thyroid 27(9):1185–1193. https://doi.org/10.1089/thy.2017.0126

Article  CAS  PubMed  Google Scholar 

Olejarz M, Szczepanek-Parulska E, Ostalowska-Klockiewicz, A et al (2023) High IgG4 serum concentration is associated with active Graves’ orbitopathy. Front Endocrinol 14:1083321. https://doi.org/10.3389/fendo.2023.1083321

Article  Google Scholar 

Umehara H, Okazaki K, Kawa S et al (2021) The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 31(3):529–533. https://doi.org/10.1080/14397595.2020.1859710

Article  CAS  PubMed  Google Scholar 

Masaki Y, Kurose N, Yamamoto M et al (2012) Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease. Int J Rheumatol 2012:580814. https://doi.org/10.1155/2012/580814

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bartalena L, Kahaly GJ, Baldeschi L et al (2021) The 2021 European group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of graves’ orbitopathy. Eur J Endocrinol 185:G43–G67

Article  CAS  PubMed  Google Scholar 

Olejarz M, Szczepanek-Parulska E, Dadej D et al (2021) IgG4 as a biomarker in Graves’ orbitopathy. Mediators Inflammat 2021:5590471. https://doi.org/10.1155/2021/5590471

Article  CAS  Google Scholar 

Sarić Matutinović M, Kahaly GJ, Žarković M et al (2023) The phenotype of Graves’ orbitopathy is associated with thyrotropin receptor antibody levels. J Endocrinol Invest. https://doi.org/10.1007/s40618-023-02085-5

Article  PubMed  Google Scholar 

Eckstein A, Esser J, Mann K et al (2010) Clinical value of TSH receptor antibodies measurement in patients with Graves’ orbitopathy. Pediatr Endocrinol Rev 7(Suppl 2):198–203

PubMed  Google Scholar 

Nicolì F, Lanzolla G, Mantuano M et al (2021) Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy. J Endocrinol Invest 44(3):581–585. https://doi.org/10.1007/s40618-020-01353-y

Article  CAS  PubMed  Google Scholar